June 1, 2007 — Abbott announced it has completed its application to the U.S. Food and Drug Administration (FDA) to seek market approval for its XIENCE V Everolimus Eluting Coronary Stent System to treat coronary artery disease, with the submission of the final module of its Pre-Market Approval (PMA) application.

June 1, 2007 — Siemens recently announced the introduction of Syngo DynaCT Cardiac, which provides three-dimensional displays of the ventricle, even during an intervention.

June 1, 2007 —ZOLL Medical Corporation, a manufacturer of resuscitation devices and related software solutions, was named one of America’s 100 Most Trustworthy Companies by Forbes.

Of the approximately 8,500 public companies reviewed to compile the list, ZOLL ranked 25th and was among only three Medical Equipment & Supplies companies listed.

June 1, 2007 — New findings show that the majority of people untrained in how to perform cardiopulmonary resuscitation, and even many trained emergency personnel, do not push with enough force to properly administer CPR.

The research tested 104 adults untrained in CPR and 83 firefighters trained in the procedure. Findings showed that most of the untrained people simply do not apply enough force, according to Leslie Geddes, Purdue University's Showalter Distinguished Professor Emeritus of Biomedical Engineering.

May 31 -- Cardiac Science Corp. announced today it has entered into a two-year marketing partnership with the City of Minneapolis, serving as the recommended provider of automated external defibrillators (AEDs) to participants in Minneapolis Project Heart Beat, the city's public access defibrillation (PAD) program. The agreement is renewable annually for three additional years.

May 31, 2007 - The American Heart Association is launching a community-based program to reduce the toll of the deadliest kind of heart attack: an ST-elevation myocardial infarction (STEMI).

The total blockage of a coronary artery is fatal unless treated quickly — within 30 minutes for clot-dissolving drug treatment, and within 90 minutes for angioplasty.

May 31, 2007 — MediNotes Corporation, a leading provider of best-of-breed electronic medical record solutions for small to medium primary care and specialty medical practices, announced today that they have partnered with Welch Allyn, a leading global manufacturer of frontline medical products and solutions to integrate the Welch Allyn family of connected cardiopulmonary and electronic vital signs devices with MediNotes e version 5.1, the company's point-of-service, wireless data collection and documentation system.

May 30, 2007 — Cardiovascular Associates, Kingsport, TN, has announced the successful implant of a new investigational cardiac medical device called the Optimizer for the treatment of heart failure.

The Optimizer, made by Impulse Dynamics, is an implantable pulse generator that delivers electrical impulses to the heart for patients who suffer from moderate-to-severe heart failure. This procedure was performed at Holston Valley Medical Center, Heart Institute on Wednesday, May 23rd.

May 30, 2007 -- Xtalks and eResearchTechnology will present a Web conference titled, "Best Practices in Cardiac Safety Data Collection Before and After the Thorough QT Trial," on June 7, 10 a.m. to noon, EDT.

May 30, 2007 -- As concern and investigation continue concerning the link between drug-eluting stents and late-stent thrombosis, focus is now turning to the issue of improperly implanted stents by physicians. "The Wall Street Journal" reports this week that cardiologists' overconfidence in the benefits of drug-coated stents may have contributed to sloppy technique.

A recent study sponsored by a stent maker, states the Journal, found that two-thirds of the stents were implanted incorrectly.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now